Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort
作者: Zhou GLiu XWang X Jin DChen YLi GLi CFu DXu WWang X
刊名: OncoTargets and Therapy, 2017, Vol.Volume 10 , pp.1199-1206
来源数据库: Directory of Open Access Journals
关键词: Pancreatic adenocarcinomaPrognosisTumor biomarkers
原始语种摘要: Guofeng Zhou,1,2,* Xiaoyu Liu,1–4,* Xiaoyi Wang,5,* Dayong Jin,6 Yi Chen,1,2 Guoping Li,1,2 Changyu Li,1,2 Deliang Fu,5 Wanghong Xu,3,4 Xiaolin Wang1,2 1Shanghai Institute of Medical Imaging, 2Department of Interventional Radiology, Zhongshan Hospital, 3Department of Epidemiology, School of Public Health, 4Key Laboratory of Public Health Safety, Ministry of Education, 5Department of Pancreatic Surgery, Institute of Pancreatic Disease, Huashan Hospital, 6Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China *These authors contributed equally to this work Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies with a 5-year survival rate of <7%. Carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic...
全文获取路径: PDF下载  DOAJ  (合作)
影响因子:2.073 (2012)

  • preoperative 操作前的
  • adenocarcinoma 腺癌
  • resectable 可切除的
  • pancreatic 胰的
  • prediction 预报
  • prognosis 预报
  • prognostic 预测的
  • survival 生存
  • resectability 切除可能性
  • malignancy 恶性